Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Immunology analyzer Mago 4

Product Image
Product Description

•    Open immunoanalytical system - Custom/user programmable channels
•    Automation of  ELISA, IFA and agglutination tests processing simultaneously in one batch
•    104 samples, barcodes, disposable tips
•    Performs up to 12 ELISA tests (on 4 microplates), or up to 16 IFA tests (slides)
•    Levey-Jennings and Westgards rules program on board

Wide range offer of EIA (ELISA) and IFA tests:

Autoimmune disease
Is®ANA ELISA screen, Is®ENA ELISA screen,
ANA Hep-2 Cells IFA, …

Infection disease

Syphilis, CMV, EBV, Toxoplasma, ...

Allergy and food intolerance

IgE, spec. IgE, kapalné alergeny, Anti-Gliadin,
Anti-Tissue-Transglutaminase, ...

Functional characteristics
•    Simultaneously 4 microplates or 16 IFA slides in one run
•    Up to 12 ELISA methods or 16 IFA methods
•    104 sample positions and 192 predilution positions  
•    27 positions for reagents, standards and controls
•    Integrated barcode reader
•    Bidirectional connection with LIS (RS232, LAN, USB)
•    Liquid level sensor
•    Optimization of incubation conditions
•    2 wash solutions (2 x 2l)
•    Test results validation based on predefined conditions/rules
•    Free space for programming up to 500 methods

Parameters
•    Integrated ELISA reader, halogen lamp, interference filtres 405, 450, 492, 620 (two free positions)
•    Westgards rules and Levey-Jennings charts on board
•    Windows XP software platform
•    Dimensions (120 x 69,5 x 60 cm)
•    Weight 85 Kg

Product Immunology analyzer Mago 4
Company Erba Group
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Erba Group
Karásek 1d, 621 33 Brno

Tel: +420 517 077 111,
Fax: +420 517 077 077
Email: diagnostics@erbalachema.com



Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!